Gynecologic Oncology | Robert Coleman, MD

Beyond the Guidelines: Perspectives on the Role of PARP Inhibition in the Management of Ovarian Cancer — Faculty Presentation 3: Potential Role of PARP Inhibitors with Chemotherapy; Other Investigational Combination Approaches in Clinical Development for Advanced OC — Dr Coleman CME information and select publications